Recombinant multi-species MEF2D protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MEF2D protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the myocyte-specific enhancer factor 2 (MEF2) family of transcription factors. Members of this family are involved in control of muscle and neuronal cell differentiation and development, and are regulated by class II histone deacetylases. Fusions of the encoded protein with Deleted in Azoospermia-Associated Protein 1 (DAZAP1) due to a translocation have been found in an acute lymphoblastic leukemia cell line, suggesting a role in leukemogenesis. The encoded protein may also be involved in Parkinson disease and myotonic dystrophy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2012]
The Alternative Names of target: MEF2D,Mef2d,Myocyte-specific enhancer factor 2D

Target products collectionGo to MEF2D products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP8825-Ag-1/ GM-Tg-hg-IP8825-Ag-2 Human MEF2D protein Human
GM-Tg-rg-IP8825-Ag-1/ GM-Tg-rg-IP8825-Ag-2 Rat MEF2D protein Rat
GM-Tg-mg-IP8825-Ag-1/ GM-Tg-mg-IP8825-Ag-2 Mouse MEF2D protein Mouse
GM-Tg-cynog-IP8825-Ag-1/ GM-Tg-cynog-IP8825-Ag-2 Cynomolgus/Rhesus macaque MEF2D protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP8825-Ag-1/ GM-Tg-felg-IP8825-Ag-2 Feline MEF2D protein Feline
GM-Tg-cang-IP8825-Ag-1/ GM-Tg-cang-IP8825-Ag-2 Canine MEF2D protein Canine
GM-Tg-bovg-IP8825-Ag-1/ GM-Tg-bovg-IP8825-Ag-2 Bovine MEF2D protein Bovine
GM-Tg-equg-IP8825-Ag-1/ GM-Tg-equg-IP8825-Ag-2 Equine MEF2D protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP8825-Ag-1/ GM-Tg-hg-IP8825-Ag-2; GM-Tg-rg-IP8825-Ag-1/ GM-Tg-rg-IP8825-Ag-2;
GM-Tg-mg-IP8825-Ag-1/ GM-Tg-mg-IP8825-Ag-2; GM-Tg-cynog-IP8825-Ag-1/ GM-Tg-cynog-IP8825-Ag-2;
GM-Tg-felg-IP8825-Ag-1/ GM-Tg-felg-IP8825-Ag-2; GM-Tg-cang-IP8825-Ag-1/ GM-Tg-cang-IP8825-Ag-2;
GM-Tg-bovg-IP8825-Ag-1/ GM-Tg-bovg-IP8825-Ag-2; GM-Tg-equg-IP8825-Ag-1/ GM-Tg-equg-IP8825-Ag-2
Products Name MEF2D protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MEF2D
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MEF2D protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.